EU vs US Cosmetic Regulations: Why Your Products Have Different Formulas

If you've ever picked up the same moisturizer in Paris and New York and noticed slightly different ingredient lists on the back, you've encountered one of the most significant — and frequently misunderstood — divides in global cosmetic regulation. The European Union's cosmetics framework currently lists over 1,600 prohibited or restricted substances. The United States, under the Federal Food, Drug, and Cosmetic Act, formally restricts or bans roughly 30. That gap is real, but what it actually means for your skin — and your safety — is considerably more nuanced.

A Tale of Two Regulatory Philosophies

The modern EU cosmetics framework traces its origins to the European Cosmetics Directive 76/768/EEC, passed in 1976, which established harmonized safety standards across member states. It was superseded by Regulation (EC) No 1223/2009, which took full effect in 2013 and remains the governing law today. This regulation introduced mandatory safety assessments by qualified safety assessors, a Responsible Person concept, and centralized notification through the Cosmetic Products Notification Portal (CPNP).

The United States operates under the Federal Food, Drug, and Cosmetic Act of 1938 — legislation passed primarily in response to a sulfanilamide drug disaster that killed over 100 people. The FD&C Act classifies cosmetics as distinct from drugs and places the primary responsibility for safety on the manufacturer. The FDA does not pre-approve cosmetic products before they reach store shelves (with the exception of color additives, which require FDA approval). Regulatory action typically follows demonstrated harm or a finding of "adulteration" under the Act.

The core philosophical difference: the EU asks "can we demonstrate this is safe enough to permit?" while the US historically asks "can we demonstrate this is unsafe enough to prohibit?" Both frameworks aim at the same goal — protecting consumers — but the burden of proof falls differently.

This distinction is embodied in the EU's application of the precautionary principle: if a substance raises credible safety concerns — even without definitive proof of harm — the EU may act preemptively. The US framework tends toward a risk-based approach, weighing actual evidence of harm against exposure levels and product use patterns before restricting an ingredient.

The Numbers in Context: 1,600+ vs. ~30

The often-cited figure of "1,600+ banned EU ingredients versus 11 (or ~30) US-banned ingredients" requires context to be meaningful. The EU's Annex II list contains substances that include many industrial chemicals, pesticides, pharmaceutical compounds, and laboratory reagents that are not used in cosmetics anywhere in the world. Many were proactively listed as prohibited precisely because they are pharmaceutical or hazardous industrial compounds, not because a cosmetics manufacturer was about to use them.

The functionally significant regulatory divergence involves a much smaller subset — perhaps 30 to 60 substances that are or were in active commercial cosmetic use and are permitted in the US while being restricted or banned in the EU. These include UV filters, certain preservatives, specific colorants, and hair dye intermediates. The table below summarizes five categories where the divergence is clearest and most relevant to everyday products.

Five Key Ingredient Divergences

1. Triclosan — Antimicrobial / Preservative

Triclosan is a broad-spectrum antimicrobial agent used in toothpastes, soaps, deodorants, and some skincare products. Its regulatory trajectory illustrates exactly how different the EU and US approaches can be.

In the EU, triclosan is listed on Annex III (restricted, not banned outright) of Regulation 1223/2009. Its use is permitted only in specific product categories at defined maximum concentrations: up to 0.3% in toothpaste, handsoap, body wash, and deodorant, with explicit prohibition in products for oral hygiene other than toothpaste and in rinse-off foot products. Mouthwash, nail products, and leave-on applications are prohibited. The European Scientific Committee on Consumer Safety (SCCS) issued its Opinion in 2011 (SCCS/1414/11) concluding the existing restrictions were scientifically justified on concerns including potential endocrine activity and antimicrobial resistance contributions.

In the US, the FDA in 2016 banned triclosan from consumer antiseptic wash products (soaps and body washes) under 21 CFR Part 310, finding manufacturers had not demonstrated it was "generally recognized as safe and effective." However, triclosan remains permitted in toothpaste (the FDA cited Colgate's clinical data as sufficient justification for that specific application) and in some other product categories. The FDA ruling did not constitute a blanket prohibition — it was specific to over-the-counter antiseptic washes.

2. Formaldehyde-Releasing Preservatives

Formaldehyde itself is regulated in both jurisdictions — the EU permits it as a preservative up to 0.2% in cosmetics (0.1% in oral hygiene products) with mandatory labeling of "contains formaldehyde" above 0.05% free formaldehyde. See formaldehyde in our database for full regulatory data.

The more practically significant issue is with formaldehyde-releasing preservatives — compounds like DMDM hydantoin, imidazolidinyl urea, diazolidinyl urea, and quaternium-15 that release formaldehyde slowly over time in a product. These are widely used US preservatives. In the EU, they are subject to the same 0.2% formaldehyde limit, and some individual releasers face additional restrictions. The SCCS has repeatedly reviewed these compounds, and several have progressively tighter concentration limits under EU amendments.

2-Bromo-2-nitropropane-1,3-diol (bronopol) illustrates the divergence: permitted as a preservative in US cosmetics, it is restricted in the EU to rinse-off products at 0.1% and prohibited in products intended for mucous membranes, due to its potential to form nitrosamines. The EU's stance on nitrosamine-forming ingredients is considerably stricter across the board.

3. Coal Tar Dyes and Color Additives

Coal tar itself is used in the EU and US in certain medicated scalp products (dandruff shampoos, psoriasis treatments) at specified concentrations. The coal tar dye issue is distinct and relates to synthetic petroleum-derived colorants.

The US FDA operates a system of certified color additives (FD&C and D&C colors) that have undergone FDA review. Many of these — particularly D&C Red No. 3, FD&C Red No. 40, FD&C Yellow No. 5, FD&C Yellow No. 6 — are broadly permitted in the US. In the EU, color additives are governed by Annex IV of Regulation 1223/2009, which operates as a positive list: only those explicitly listed are permitted, at specified concentrations and in specified product types.

Several colors used extensively in US cosmetics either do not appear on EU Annex IV or appear with significantly restricted use conditions (e.g., eye-area only vs. full-face restriction, or rinse-off only). This means a US mascara and its EU-market equivalent may literally have different pigment formulations, even when sold under the same product name.

4. Lead Acetate — Hair Dye / Colorant

Lead acetate was used for decades in the US in "progressive" hair color products — gradual-darkening hair dyes that work by depositing lead sulfide on the hair shaft as the lead reacts with sulfur in proteins. The most prominent commercial application was Grecian Formula.

In the EU, lead acetate has been prohibited in cosmetic products since 1997 under the Cosmetics Directive, reflecting the EU's broad precautionary approach to heavy metals in cosmetics. Lead is a known neurotoxin with no established safe threshold for systemic exposure.

In the US, the FDA permitted lead acetate in hair dyes at concentrations up to 0.6% (as lead) under 21 CFR § 73.2396 for decades. The FDA finally revised its position in 2018, formally revoking the color additive authorization for lead acetate in hair dyes, citing updated safety evidence. This brought the US closer to the EU position, though the EU had acted over two decades earlier.

5. Mercury Compounds — Preservatives and Skin Lighteners

Mercury compounds — historically used as preservatives (thimerosal in eye makeup) and as skin-lightening agents (mercurous chloride, ammoniated mercury) — represent a rare case where the US has effectively prohibited the same compounds as the EU, but through different regulatory mechanisms.

Under 21 CFR Part 700.13, the FDA prohibits mercury compounds in cosmetics at concentrations above 1 ppm (trace contamination tolerance), with a narrow exception for eye-area cosmetics where no adequate mercury-free preservative alternative existed (thimerosal in some contact lens solutions at ≤65 ppm). However, the FDA specifically notes this exception no longer applies to cosmetics that contain available alternatives.

The EU prohibits all mercury compounds in cosmetics under Annex II (substance number 221–222 on the prohibited list). The practical convergence between the EU and US on mercury reflects how global scientific consensus, when it forms clearly, does eventually drive regulatory alignment — even across different frameworks.

UV Filters: The Most Technically Complex Divergence

Perhaps the most technically significant current divergence involves UV filters for sunscreens. In the EU, sunscreens are regulated as cosmetics, and the EU has approved more than 27 UV filter substances. In the US, sunscreens are regulated as over-the-counter (OTC) drugs under an FDA monograph system, which creates a different regulatory pathway.

As of 2025, the FDA has only two UV filters in Category I (generally recognized as safe and effective) status: zinc oxide and titanium dioxide. Twelve others — including avobenzone, oxybenzone, octinoxate, and octocrylene — are in Category III status (insufficient data to determine GRASE status) following the FDA's 2019 and 2021 proposed rules. Many newer EU-approved filters, such as bemotrizinol (Tinosorb S) and bisoctrizole (Tinosorb M), have not been approved by the FDA.

For a detailed country-by-country UV filter comparison, see our guide: UV Filters Compared: Which Sunscreen Ingredients Are Approved Where?

Regulatory Comparison at a Glance

Dimension	European Union	United States
Governing law	Regulation (EC) No 1223/2009	FD&C Act (1938) + FTC
Product pre-approval	No pre-market approval (but mandatory safety assessment & Responsible Person)	No pre-market approval (color additives are exceptions)
Prohibited substances list	Annex II: 1,600+ substances	~30 explicitly prohibited by FDA rule
Color additives	Positive list (Annex IV) — only listed colors permitted	FDA-certified color additives permitted; others prohibited
Sunscreen classification	Cosmetic product	OTC drug (monograph system)
Regulatory philosophy	Precautionary principle	Risk-based (demonstrated harm required)
Safety assessment requirement	Mandatory qualified safety assessor	Manufacturer's responsibility; no mandatory third-party assessment
Labeling (INCI)	Mandatory INCI list on product	Mandatory ingredient declaration (21 CFR § 701.3) in INCI-aligned format

What Changed in the US: The Modernization of Cosmetics Regulation Act (MoCRA) 2022

The US regulatory landscape is not static. The Modernization of Cosmetics Regulation Act of 2022 (MoCRA), signed into law in December 2022, represents the most significant update to US cosmetics law since 1938. Key provisions include:

• Mandatory facility registration with the FDA for cosmetic manufacturers and processors.
• Product listing requirements — brands must list cosmetic products with the FDA, including ingredient disclosures.
• Adverse event reporting — serious adverse events must be reported to the FDA within 15 business days.
• Good Manufacturing Practice (GMP) requirements, to be established via FDA rulemaking.
• Fragrance allergen disclosure requirements on product labels, bringing the US closer to EU practice.
• FDA recall authority for unsafe cosmetics (previously voluntary recalls only).

MoCRA does not dramatically expand the list of prohibited ingredients, but it substantially increases the FDA's authority and the accountability of cosmetics manufacturers. Full implementation of MoCRA requirements is rolling out through 2024–2026.

Practical Implications for Consumers and Formulators

For consumers purchasing products globally — online imports, travel purchases, or cross-border gifting — the regulatory status of an ingredient in your country of use is what governs legality and labeling requirements. A product formulated for the EU market may not be compliant with US FDA labeling rules, and vice versa, even if both are considered "safe" by their respective regulatory bodies.

For formulators working in multiple markets, the practical strategy is typically to formulate to the most restrictive common standard when launching globally — which often means EU compliance as the baseline, then checking whether any EU-restricted ingredients create OTC drug classification issues in the US (particularly for UV filters and anti-dandruff actives).

For consumers concerned about specific ingredients, the most reliable approach is to check the ingredient's status in the specific country's regulatory database directly: the EU's CosIng database for EU status, the FDA's prohibited/restricted ingredients list for US status. Our Ingredient Analyzer aggregates regulation status from both jurisdictions across our database of 1,898 ingredients.